BioLASCO Taiwan Co., Ltd. (TPEX:6662)

BioLASCO Taiwan Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72.26	106.82	142.97	168.5	201.17	201.47
Short-Term Investments	55.7	55.7	58.7	58.7	43.3	43.3
Cash & Short-Term Investments	127.96	162.52	201.67	227.2	244.47	244.77
Cash Growth	-7.95%	-19.41%	-11.24%	-7.06%	-0.12%	-15.64%
Accounts Receivable	39.07	44.48	49.41	31.35	30.51	49.38
Receivables	39.07	44.48	49.41	31.35	30.51	49.38
Inventory	29.5	37.84	34.3	26.22	19.34	21.07
Prepaid Expenses	1.2	1.03	1.04	0.8	0.71	0.67
Other Current Assets	2.8	3.41	3.43	1.76	2.06	0.12
Total Current Assets	200.53	249.28	289.84	287.34	297.08	316
Property, Plant & Equipment	252.34	237.64	190.71	197.13	199.35	203.01
Long-Term Investments	121.85	116.94	83.29	72.76	64.51	52.27
Other Intangible Assets	0.23	0.33	0.34	0.46	0.1	0.02
Long-Term Deferred Tax Assets	2.91	1.99	2.65	4.29	5.25	5.77
Other Long-Term Assets	6.85	6.48	6.3	7.71	7.98	12.32
Total Assets	584.69	612.67	573.14	569.69	574.26	589.38
Accounts Payable	8.07	19.61	5.49	8.44	5.67	4.42
Accrued Expenses	12.97	17.97	17.74	16.55	15.91	19.4
Current Portion of Long-Term Debt	13.1	11.27	5.33	5.33	5.33	5.33
Current Portion of Leases	1.21	1.14	1.44	2.41	0.83	1.67
Current Income Taxes Payable	1.32	5.1	10.6	9.63	10.69	8.43
Current Unearned Revenue	6.99	1.65	7.77	3.96	2.66	3.37
Other Current Liabilities	11.18	11.36	11.69	10.1	9.06	9.85
Total Current Liabilities	54.84	68.1	60.07	56.42	50.14	52.46
Long-Term Debt	85.05	94.52	51.28	56.61	61.94	66.92
Long-Term Leases	1.3	0.08	0.16	1.6	1.07	0.21
Pension & Post-Retirement Benefits	-	-	-	-	0.44	1.74
Long-Term Deferred Tax Liabilities	0.57	0.59	0.48	0.43	0.32	0.27
Total Liabilities	141.75	163.29	111.98	115.05	113.91	121.6
Common Stock	256.12	256.12	256.12	256.12	256.12	256.12
Additional Paid-In Capital	84.11	95.64	95.64	102.04	102.04	102.04
Retained Earnings	124.21	125.7	123.6	105.81	104.01	109.21
Comprehensive Income & Other	-21.51	-28.09	-14.21	-9.34	-1.82	0.41
Total Common Equity	442.94	449.38	461.16	454.64	460.36	467.79
Shareholders' Equity	442.94	449.38	461.16	454.64	460.36	467.79
Total Liabilities & Equity	584.69	612.67	573.14	569.69	574.26	589.38
Total Debt	100.66	107.01	58.21	65.95	69.18	74.13
Net Cash (Debt)	27.3	55.51	143.46	161.26	175.29	170.64
Net Cash Growth	-7.88%	-61.31%	-11.04%	-8.01%	2.73%	-38.31%
Net Cash Per Share	1.06	2.16	5.59	6.28	6.83	6.65
Filing Date Shares Outstanding	25.61	25.61	25.61	25.61	25.61	25.61
Total Common Shares Outstanding	25.61	25.61	25.61	25.61	25.61	25.61
Working Capital	145.69	181.19	229.78	230.92	246.94	263.53
Book Value Per Share	17.29	17.55	18.01	17.75	17.97	18.26
Tangible Book Value	442.71	449.05	460.82	454.18	460.26	467.76
Tangible Book Value Per Share	17.29	17.53	17.99	17.73	17.97	18.26
Land	-	149.68	117.39	117.39	117.39	117.39
Buildings	-	114.09	102.5	102.5	102.5	101.12
Machinery	-	28.35	25.4	24.22	23.52	22.48
Construction In Progress	-	5.6	-	-	-	-
Leasehold Improvements	-	-	0.38	-	5.32	5.24

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.